Stock Events

Stock Events

Enliven Therapeutics (ELVN) Q2 2023 Earnings

10AugConfirmed

Q3 2022

Q4 2022

Q1 2023

Q2 2023

-0.79

-0.12

0.54

1.21

Details

Expected EPS

-0.36

Actual EPS

-0.41

Surprise EPS

-0.05

Surprise Percent

+13.89%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.41 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.